Mersana Therapeutics Obtains $35,000,000 Series B Financing

  • Feed Type
  • Date
    3/2/2015
  • Company Name
    Mersana Therapeutics
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139 USA
  • Company Description
    Mersana Therapeutics, Inc. (formerly Nanopharma Corp.) is focused on developing novel oncology agents based on Fleximer, a stealth material that enhances the pharmacokinetics and safety of drugs.
  • Website
    http://www.mersana.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $35,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The proceeds will fund the advancement of Mersana’s pipeline of products based on its novel Fleximer antibody-drug conjugate (ADC) platform with its first investigational new drug (IND) filing anticipated later this year.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy